Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?
Titel:
Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?
Auteur:
Vera, Ruth Mata, Elena González, Encarna Juez, Ignacio Alonso, Vicente Iranzo, Patricia Martínez, Nieves P. López, Carlos Cabrera, José M. Safont, María J. Ruiz-Casado, Ana Salgado, Mercedes González, Beatriz Escudero, Pilar Rivera, Fernando Pericay, Carles